Israel Innovation Authority
Government organization
Active
Jerusalem, Israel
150
1M
123
2.54
37
0.18
10
- Areas of investment
Summary
The leading representative office of defined Corporate Investor is situated in the Jerusalem. The company was established in Asia in Israel.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Reduxio, BioTime, ElastiMed. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. We can highlight the next thriving fund investment areas, such as Therapeutics, Agriculture.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Israel Innovation Authority, startups are often financed by EASME - EU Executive Agency for SMEs, Israel Healthcare Ventures, Viola Ventures. The meaningful sponsors for the fund in investment in the same round are ShengJing360, iVentures Asia Ltd, Trendlines Group. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, Fresenius Medical Care, National Multiple Sclerosis Society (NMSS).
Speaking about the real fund results, this Corporate Investor is 27 percentage points more often commits exit comparing to other organizations. This Israel Innovation Authority works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2017. Deals in the range of 1 - 5 millions dollars are the general things for fund. The top amount of exits for fund were in 2019. The fund is generally included in 7-12 deals every year.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 150
- Lead investments
- 37
- Exits
- 10
- Rounds per year
- 2.54
- Follow on index
- 0.18
- Investments by industry
- Health Care (46)
- Medical Device (30)
- Biotechnology (30)
- Artificial Intelligence (27)
- Medical (27) Show 151 more
- Investments by region
-
- Israel (122)
- United States (16)
- Mali (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 0.39
- Avg. company exit year
- 7
- Avg. multiplicator
- 1.31
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| DermaDetect | 01 Jan 2022 | Artificial Intelligence, Health Care, Health Diagnostics, Medical Device, Personal Health, Therapeutics | Seed | 2M | Tel Aviv District, Tel Aviv-Yafo, Israel |
| Silib | 29 Aug 2021 | Energy Storage, Energy, Battery | Seed | 3M |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.